摘要
乳腺癌相关淋巴水肿(BCRL)是乳腺癌手术和放疗后最常见的并发症之一。目前可采用物理方法和手术方法进行治疗。早期的手术效果有限。现代微侵袭外科技术能有效地改善BCRL。新型的干细胞治疗为BCRL的治疗提供了一种很有前景的选择。该文对近年来BCRL的最新治疗进展进行文献综述,希望能更多地了解BCRL的治疗进展,适当选择治疗,使患者从中获益。
Breast cancer-related upper extremity lymphedema(BCRL)is one of the most common complications after breast cancer surgery and radiation therapy.At present,physical methods and surgical methods can be used for treatment.Early surgical procedures had only limited effect.However,contemporary minimally invasive surgical techniques have been shown to be effective in ameliorating BCRL.The new type stem cell therapy provides a promising alternative in the treatment of BCRL.This review provides an overview of recent progress in the treatment of BCRL.It is hope to more understand the current treatment progress of BCRL,appropriately choose treatment and make patients benefit from it.
作者
余富杰
赵大威(综述)
蒋小娟(审校)
YU Fujie;ZHAO Dawei;JIANG Xiaojuan(Department of Breast and Thyroid Surgery,Institute of Field Surgery Research,Daping Hospital,Army Military Medical University,Chongqing 400042,China;Department of Neurosurgery,Southwest Hospital,Army Military Medical University,Chongqing,400038,China)
出处
《重庆医学》
CAS
2021年第23期4115-4119,共5页
Chongqing medicine
基金
重庆市科卫联合医学科研项目(2020FYYX116)。
关键词
乳腺肿瘤
淋巴水肿
保守治疗
手术治疗
干细胞移植
breast neoplasms
lymphedema
expectant treatment
operative treatmene
stem cell transplantation
